Though some areas of Strategies for Engineered Negligible Senescence (SENS), such as stem cells and amyloid immunotherapy, are sufficiently mainstream not to need Methuselah Foundation funding, most are still relative backwaters that rely on the MF to progress. IEET fellow gives an overview of the research projects that the MF is now funding, their significance to SENS, and their potential to lead to accelerated progress towards the defeat of aging in 2009 and beyond.

SENS Progress Worldwide from Jeriaska on Vimeo.

DOWNLOAD/LISTEN/VIEW:

http://vimeo.com/3610985